Cargando…

Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes

OBJECTIVE: To assess the relationship between osteoprotegerin (OPG) and cardiovascular death, and the pathobiological mechanisms contributing to the association, in acute coronary syndromes (ACS). DESIGN: Prospective observational. SETTING: Biomarker substudy of MERLIN-TIMI 36, a randomised, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Røysland, Ragnhild, Bonaca, Marc P, Omland, Torbjørn, Sabatine, Marc, Murphy, Sabina A, Scirica, Benjamin M, Bjerre, Mette, Flyvbjerg, Allan, Braunwald, Eugene, Morrow, David A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Biomarkers and Heart Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341671/ https://www.ncbi.nlm.nih.gov/pubmed/22373720 http://dx.doi.org/10.1136/heartjnl-2011-301260

Ejemplares similares

High-sensitivity cardiac troponin T levels are increased in stable COPD
por: Neukamm, Anke M C, et al.
Publicado: (2013)

Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes
por: Zelniker, Thomas A., et al.
Publicado: (2019)

Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure
por: Miller, Wayne L, et al.
Publicado: (2011)

Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
por: Berge, Kristian, et al.
Publicado: (2022)

Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study
por: Røysland, Ragnhild, et al.
Publicado: (2016)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
por: Gordin, Daniel, et al.
Publicado: (2013)

Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)‐TIMI 50
por: Kidd, Stephen K., et al.
Publicado: (2016)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013)

ASSOCIATION BETWEEN SYMPTOM DURATION AND CLINICAL OUTCOMES IN PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION
por: Cha, Jung-Joon, et al.
Publicado: (2022)

The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project
por: Caspersen, Nina F., et al.
Publicado: (2018)

Sex Differences in Outcome and Prescribing Practice in ST-elevation MI Patients with Multivessel Disease and Incomplete Revascularisation
por: Burgess, Sonya, et al.
Publicado: (2023)

Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
por: Cavender, Matthew A., et al.
Publicado: (2015)

Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P‐TIMI 50
por: Berg, David D., et al.
Publicado: (2021)

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
por: Magnani, Giulia, et al.
Publicado: (2015)

Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P‐TIMI 50 trial
por: Freedman, Benjamin L., et al.
Publicado: (2022)

Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2°P‐TIMI 50 trial
por: Freedman, Benjamin L., et al.
Publicado: (2023)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Metabolomics of World Trade Center-Lung Injury: a machine learning approach
por: Crowley, George, et al.
Publicado: (2018)

The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease
por: Khan, Fasihul, et al.
Publicado: (2019)

Non-invasive testing for liver pathology in alpha-1 antitrypsin deficiency
por: Abbas, Syed Hamza, et al.
Publicado: (2020)

Performance evaluation of human cough annotators: optimal metrics and sex differences
por: Sanchez-Olivieri, Isabel, et al.
Publicado: (2023)

Escalating incidence of infective endocarditis in Europe in the 21st century
por: Talha, Khawaja M, et al.
Publicado: (2021)

Relationship Between Exposure to Sulphur Dioxide Air Pollution, White Cell Inflammatory Biomarkers and Enzymatic Infarct Size in Patients With ST-segment Elevation Acute Coronary Syndromes
por: Díaz-Chirón, Laura, et al.
Publicado: (2021)

Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study
por: Opinc, Aleksandra, et al.
Publicado: (2020)

Prognostic value of soluble ST2 in adults with congenital heart disease
por: Geenen, Laurie W, et al.
Publicado: (2019)

Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias
por: Scheirlynck, Esther, et al.
Publicado: (2019)

ST-segment elevation in a patient with cardiac lymphoma
por: Guimarães, J. P., et al.
Publicado: (2019)

Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
por: Gehin, Johanna E., et al.
Publicado: (2021)

Inferior acute myocardial infarction with anterior ST-segment elevations
por: Bouhuijzen, L. J., et al.
Publicado: (2018)

Double venous drainage through the superior vena cava in minimally invasive aortic valve replacement: a retrospective study
por: Klokočovnik, Tomislav, et al.
Publicado: (2012)

Influence of coronary computed tomography-angiography on patient management
por: Jukić, Mladen, et al.
Publicado: (2012)

Periodontitis is an independent risk indicator for atherosclerotic cardiovascular diseases among 60 174 participants in a large dental school in the Netherlands
por: Beukers, Nicky G F M, et al.
Publicado: (2017)

Spontaneous Coronary Artery Dissection: Mechanisms, Diagnosis and Management
por: Garcia-Guimarães, Marcos, et al.
Publicado: (2020)

Applications for Induced Pluripotent Stem Cells in Disease Modelling and Drug Development for Heart Diseases
por: Nakao, Shu, et al.
Publicado: (2020)

Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control
por: Jacobsen, Daniel P., et al.
Publicado: (2022)

Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020)

Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016)

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study
por: Welsh, Paul, et al.
Publicado: (2017)

Morbidity outcomes after surgical aortic valve replacement
por: Auensen, Andreas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0s3pgcq1qrvqiapvfn4ul36m01